VACCINE ADJUVANT

We describe a conjugate comprising a CD40 ligand and an antigen wherein said conjugate has adjuvant activity and particularly, but not exclusively, the use of the conjugate in vaccination against vital diseases or conditions which result from viral infection. L'invention se rapporte à un conjug...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	HEATH, ANDREW, WILLIAM
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	We describe a conjugate comprising a CD40 ligand and an antigen wherein said conjugate has adjuvant activity and particularly, but not exclusively, the use of the conjugate in vaccination against vital diseases or conditions which result from viral infection. L'invention se rapporte à un conjugué contenant un ligand CD40 et un antigène, ledit conjugué présentant une activité adjuvante, et en particulier, mais de façon non limitative, à l'utilisation du conjugué dans la vaccination contre des maladies ou troubles viraux résultant d'une infection virale.